What CAGR is projected for diabetes devices sales between 2019 and 2027?

Transparency Market Research forecasts a 6.4% compound annual growth rate for diabetes devices sales from 2019 to 2027. This comes from its report, “Diabetes Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.”

Which product segment is expected to lead the diabetes devices market?

The Glucose Monitoring Devices segment is projected to dominate the market. The report identifies glucose monitoring as the leading category within diabetes devices during the forecast period.

Which distribution channel is considered highly lucrative for diabetes devices?

Hospital Pharmacy is highlighted as a highly lucrative segment. The study points to hospital pharmacies as a key channel for device sales.

Which region is expected to dominate the global diabetes devices market?

North America is expected to dominate the global market. The report notes North America’s leadership over the forecast horizon.

Who are some of the key players mentioned in the report?

The market is fragmented, with key players including Medtronic, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, and F. Hoffmann-La Roche. These companies are listed in the competitive landscape section.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Sales of Diabetes Devices to Rise at a Cagr of 6.4% From 2019 to 2027

Published by TMR Research Insights

Posted on August 5, 2021

5 min read

Last updated: February 18, 2026

Add as preferred source on Google

Finance Minister Andrzej Domanski discussing Poland's GDP growth forecast - Global Banking & Finance Review — Finance Minister Andrzej Domanski outlines Poland's GDP growth expectations of 2.8-2.9% for Q4 2023, emphasizing the importance of investments and exports for future economic stability.

Diabetes Device Sales Seen Growing 6.4% CAGR from 2019 to 2027

Transparency Market Research (TMR) has published a new report titled, ‘Diabetes Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global diabetes devices market was valued at US$ 41.8 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.

Overview

Diabetes is a global issue affecting millions of people every year. This has led to major technological advancements in diabetes treatment. Global diabetes care devices market exhibits a great potential and is estimated to grow exponentially by 2027.

Diabetes care devices are used to diagnose and monitor the blood glucose level into a diabetic patient’s body. The demand for minimally invasive devices has led companies to launch patient-convenient diabetes care device.

North America dominated the global diabetes devices market in 2018 and the trend is anticipated to continue during the forecast period. Large diabetes population, higher awareness, significant health care spending in the overall national budget, early availability of advanced technologies, and higher penetration of health care services across the U.S. and Canada are expected to drive the market in North America.

Asia Pacific is likely to be a highly lucrative market for diabetes devices and it is expected to expand at a high CAGR during the forecast period

Rise in Incidence of Pediatric and Geriatric Diabetes to Drive Market

The world’s population is aging rapidly, especially in some of the developed economies such as the U.S. and Japan. Developed economies present high rates of aging. According to the World Health Organization, the global geriatric population is likely to reach around 2 billion (22% of global population) by 2050 as compared to 900 million in 2015. Countries such as India, China, Thailand, and South Korea are also expected to have large geriatric populations in the shortest span of time in the near future.

Diabetes is more prevalent in the geriatric population. According to the American Diabetes Association, over 25% of the diabetic patients in the U.S. are aged 65 years and above.

Incidence of diabetes in the pediatric population is gradually increasing. Hence, rise in pediatric and geriatric diabetes is expected to fuel the growth of the diabetes devices market.

Glucose Monitoring Devices Segment to Dominate Market

Based on product type, the global diabetes devices market has been divided into glucose monitoring devices insulin delivery devices diabetes monitoring software, and artificial pancreas systems. The glucose monitoring devices segment has been bifurcated into self- monitoring blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring meters.

The insulin delivery devices segment is further classified as insulin syringes, insulin pens, and insulin pumps.

The glucose monitoring devices segment dominated the global diabetes devices market in 2018 and the trend is projected to continue during the forecast period. Wide availability of glucose monitoring devices with advanced sensors for the detection of blood sugar levels is a major driver for the segment.

Moreover, the use of wireless technology in CGM for transmitting glucose readings collected from the interstitial fluid between the patient’s skin cells, has become an important tool for monitoring type 1 diabetes.

Hospital Pharmacy to be Highly Lucrative Segment

In terms of distribution channel, the global diabetes devices market has been classified into hospital pharmacy, retail pharmacy, online pharmacy, and diabetes clinics/ centers.

Hospital pharmacies is projected to be the most attractive segment during the forecast period.

High prevalence of type 2 and 1 diabetes is anticipated to increase hospital visits. Moreover, increasing investment in R&D and promising pipeline of artificial pancreas system are anticipated to fuel the hospital pharmacies segment.

North America to Dominate Global Market

In terms of region, the global diabetes devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global diabetes devices market in 2018, followed by Europe.

North America accounted for major share of the global diabetes devices market in 2018. Its dominance can be attributed to a large diabetes population, higher awareness, and significant health care spending in the overall national budget, early availability of advanced technologies, and higher penetration of health care services across the country.

The diabetes devices market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027.

Competitive Landscape

The global diabetes devices market is fragmented in terms of number of players. Key players in the global market include Medtronic, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Tandem Diabetes Care, Inc., Abbott Laboratories, Cellnovo, Insulet Corporation, LifeScan, Inc., Owen Mumford Ltd., among others.

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research – https://www.transparencymarketresearch.com/healthcare-market-reports-42.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Sales of Diabetes Devices to Rise at a Cagr of 6.4% From 2019 to 2027

Diabetes Device Sales Seen Growing 6.4% CAGR from 2019 to 2027

Frequently Asked Questions about Sales of Diabetes Devices to Rise at a CAGR of 6.4% from 2019 to 2027